Data Bridge Market Research analyses that the multiple sclerosis treatment market was valued at USD 25.38 billion in 2021 and is expected to reach USD 34.73 billion by 2029, registering a CAGR of 4.00% during the forecast period of 2022 to 2029.

The global Multiple Sclerosis Treatment Market is accruing rapidly mainly due to the increasing prevalence of the disease.

These risk factors independently but equally contribute to the disease’s variability and may be an early influence on progression.

The global multiple sclerosis treatment market is expecting a steady growth in the near future owing to increasing prevalence of muscle weakness related problems and increasing elderly population.